Kawase, M.; Washino, S.; Nishino, T.; Yamasaki, T.; Fukushima, H.; Iwatani, K.; Miyagawa, T.; Shimbo, M.; Ohba, K.; Miki, J.;
et al. Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Diseases 2025, 13, 92.
https://doi.org/10.3390/diseases13040092
AMA Style
Kawase M, Washino S, Nishino T, Yamasaki T, Fukushima H, Iwatani K, Miyagawa T, Shimbo M, Ohba K, Miki J,
et al. Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Diseases. 2025; 13(4):92.
https://doi.org/10.3390/diseases13040092
Chicago/Turabian Style
Kawase, Makoto, Satoshi Washino, Takato Nishino, Takeshi Yamasaki, Hajime Fukushima, Kosuke Iwatani, Tomoaki Miyagawa, Masaki Shimbo, Kojiro Ohba, Jun Miki,
and et al. 2025. "Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy" Diseases 13, no. 4: 92.
https://doi.org/10.3390/diseases13040092
APA Style
Kawase, M., Washino, S., Nishino, T., Yamasaki, T., Fukushima, H., Iwatani, K., Miyagawa, T., Shimbo, M., Ohba, K., Miki, J., Nakane, K., & Koie, T.
(2025). Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Diseases, 13(4), 92.
https://doi.org/10.3390/diseases13040092
